Section 54
Chapter 53,865

Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells

Park, S.; Lee, H.-J.; Jeong, S.-J.; Song, H.S.; Kim, M.; Lee, H.-J.; Lee, E.-O.; Kim, D.-H.; Ahn, K.S.; Kim, S.-H.

Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49(6): 1367-1372


ISSN/ISBN: 1873-6351
PMID: 21420464
DOI: 10.1016/j.fct.2011.03.021
Accession: 053864022

Signal transducer and activator of transcription 3 (STAT3) is an oncogenic transcription factor implicated in carcinogenesis. Here, the role of STAT3 pathway in the antitumor activity of an active ginseng saponin metabolite compound K (CK) was investigated in human multiple myeloma U266 cells. CK increased the cytotoxicity, accumulated the sub-G1 DNA population, cleaved poly (ADP-ribose) polymerase (PARP) and activated caspase-3 in U266 cells. Interestingly, CK inhibited phosphorylation of STAT3 and its upstream activators, the Janus activated kinase 1 (JAK1), but not JAK2. Furthermore, CK enhanced the expression of protein tyrosine phosphatase (PTP) SHP-1, but not PTEN. Additionally, CK down-regulated STAT3 target genes bcl-x(L), bcl-2, survivin, cyclin E and cyclin D1. Conversely, PTP inhibitor pervanadate reversed CK-mediated STAT3 inactivation and cleavages of caspase-3 and PARP. Overall, our findings demonstrate that JAK1/STAT3 signaling mediates CK-induced apoptosis in U266 cells and also suggest the chemopreventive potential of CK for treatment of multiple myeloma.

PDF emailed within 0-6 h: $19.90